Sysmex America, Inc. has announced that its Sysmex XE-5000 Automated Hematology Analyzer has been cleared by the United States Food and Drug Administration (FDA) for sale in the U.S. The XE-5000 ...

"Sysmex's hemostasis solutions bring together advanced technology, trusted reagents and award-winning service to provide laboratories with reliable results for diagnosing patients suffering from ...

Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced plans to debut its expanded cell image analysis portfolio during this year ...

LINCOLNSHIRE, Ill., April 2, 2024 /PRNewswire/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing ...

British-based backup and recovery technology reduces labour costs by up to 75% while minimising downtime, creating a win-win for healthcare providers and patients. In healthcare settings, equipment ...

“The clinicians and physicians who are already using our ACPs have found them helpful in detecting and differentiating a wide variety of hematological conditions, including anemia, infection, ...

All of the new instruments are pending FDA 510(k) clearance and are not yet available for sale in the U.S. WAM Select(TM), a new middleware software offering that enables efficiency and control over ...

LINCOLNSHIRE, Ill., Dec. 3, 2013 /PRNewswire/ -- Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, today announced that Alex Garini has ...

LINCOLNSHIRE, Ill., Sept. 13, 2021 /PRNewswire/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing ...

Boston Therapeutics Inc., a diabetes-focused drug development company based in Manchester, N.H., named Anthony Squeglia as finance chief. The company didn't immediately disclose his compensation. From ...